Jun 18, 2018

MARLBOROUGH, Mass. (June 18, 2018) – Hologic, Inc. (Nasdaq: HOLX) announced today that it has obtained approval from Health Canada for its new Panther Fusion® system and Panther Fusion assays...

May 29, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Jefferies Global Healthcare Conference in New York, NY on Wednesday, June 6...

May 2, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that it has received a medical device license issued by Health Canada to market Cynosure’s advanced non-invasive body contouring product, SculpSure,...

More ›


SEC Filings
NASDAQHOLX
Presentations & Webcasts